FDA Announces Efforts to Implement Real-Time Clinical Trial Reporting

The FDA has launched a pilot program to establish real-time clinical trials that includes two proof-of-concept clinical trials that will report endpoints and data signals in real time. AstraZeneca is conducting TrAVeRse, a phase II trial in treatment-naïve mantle cell lymphoma, and Amgen is planning the phase Ib STREAM-SCLC study in limited-stage small cell lung carcinoma.

Publication Details

Journal
Cancer Discovery
Published
2026-06-17
DOI
https://doi.org/10.1158/2159-8290.cd-nw2026-0071
Primary Topic
Lung Cancer Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FDA Announces Efforts to Implement Real-Time Clinical Trial Reporting

Cancer Discovery
Lung Cancer Research Studies
article

FDA Announces Efforts to Implement Real-Time Clinical Trial Reporting

article en

Abstract

The FDA has launched a pilot program to establish real-time clinical trials that includes two proof-of-concept clinical trials that will report endpoints and data signals in real time. AstraZeneca is conducting TrAVeRse, a phase II trial in treatment-naïve mantle cell lymphoma, and Amgen is planning the phase Ib STREAM-SCLC study in limited-stage small cell lung carcinoma.

Cancer Discovery
Good health and well-being
Openalex Percentile: Top 12%
Lung Cancer Research Studies
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.